The “United States Non-oncology Biopharmaceuticals Market” reached a valuation of USD xx.x Billion in 2023, with projections to achieve USD xx.x Billion by 2031, demonstrating a compound annual growth rate (CAGR) of xx.x% from 2024 to 2031. United States Non-oncology Biopharmaceuticals Market by Application The United States non-oncology biopharmaceuticals market […]
Recent News